المؤلفون: Al-Chalabi A; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 9RS, UK; King's College Hospital, London SE5 9RS, UK. Electronic address: ammar.al-chalabi@kcl.ac.uk., Fang T; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 9RS, UK., Khleifat AA; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 9RS, UK., Meurgey JH; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 9RS, UK., Jones A; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 9RS, UK., Leigh PN; Department of Neurology, Brighton and Sussex Medical School, Sussex, UK., Bensimon G; Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France.

المصدر: The Lancet. Neurology [Lancet Neurol] 2018 Jul; Vol. 17 (7), pp. 579-580.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Amyotrophic Lateral Sclerosis* , Riluzole*, Data Collection ; Humans ; Retrospective Studies

SCR Disease Name: Amyotrophic Lateral Sclerosis 2, Juvenile

المؤلفون: Fang T; King's College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, London, UK., Al Khleifat A; King's College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, London, UK., Meurgey JH; King's College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, London, UK., Jones A; King's College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, London, UK., Leigh PN; Department of Neurology, Brighton and Sussex Medical School, Sussex, UK., Bensimon G; Department of Pharmacology, Hôpital Pitié-Salpêtrière, Paris, France., Al-Chalabi A; King's College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, London, UK; King's College Hospital, Denmark Hill, London, UK. Electronic address: ammar.al-chalabi@kcl.ac.uk.

المصدر: The Lancet. Neurology [Lancet Neurol] 2018 May; Vol. 17 (5), pp. 416-422. Date of Electronic Publication: 2018 Mar 07.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Disease Progression* , Outcome Assessment, Health Care* , Severity of Illness Index* , Survival Analysis*, Amyotrophic Lateral Sclerosis/*drug therapy , Excitatory Amino Acid Antagonists/*administration & dosage , Riluzole/*administration & dosage, Amyotrophic Lateral Sclerosis/mortality ; Dose-Response Relationship, Drug ; Humans ; Retrospective Studies ; Time Factors